BNTX News and Press, BioNTech SE From 05/26/24

MediLink Therapeutics announces a multi-target TMALIN® ADC technology platform license agreement with BioNTech, expanding their global strategic partnership PR Newswire SUZHOU, China , May 26, 2024 /PRNewswire/ -- MediLink Therapeutics (Suzhou) Co., Ltd. ("MediLink"...

2024-05-24 08:15:00 ET Shares of vaccine stocks Moderna (NASDAQ: MRNA) , Novavax (NASDAQ: NVAX) , and BioNTech SE (NASDAQ: BNTX) rallied this week, appreciating 23.4%, 16.4%, and 9.3%, respectively, through Thursday trading, according to data from S&P Global Ma...

2024-05-24 05:05:00 ET Summary RGA Investment Advisors are an independent, fee-only investment management firm providing wealth management and financial planning for individuals, families, non-profit firms, and corporations of all sizes. In the first quarter, the macroeconomic env...

2024-05-23 14:20:37 ET More on BioNTech, Moderna, etc. Moderna: Betting On Bird Flu Rally Is A Poor Strategy For A Value Investor The Prognosis For Pfizer Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Pfizer, Moderna in talks ...

2024-05-23 10:15:42 ET Summary Moderna's stock price is rising on fears of a new infectious disease outbreak, and this is reminiscent of the company's pandemic gains. Moderna and Pfizer have been in talks with the Department of Health and Human Services after a second case of avia...

2024-05-23 06:49:51 ET Summary Nvidia's Q1 results and guidance exceed expectations, leading to an increase in stock price and announcement of a 10-1 stock split. Live Nation Entertainment shares drop as the DOJ plans to announce an antitrust lawsuit against the company. Vacci...

2024-05-22 17:43:22 ET Several vaccine makers closed Wednesday up with double-digit percentage gains amid a report of the first avian flu case in a human in Australia and a second case in the U.S.... Read the full article on Seeking Alpha For further details see: Moderna...

2024-05-22 14:00:26 ET More on BioNTech, Moderna, etc. Pfizer: Offsetting The LOE Cliff Crisis With 6 New Potential Blockbuster Drugs Aggressive Strides Forward For Moderna's Cancer Vaccine Pfizer Stock: Rebound Has Started (Technical Analysis) Pfizer launchi...

MAINZ, Germany, May 21, 2024 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present clinical trial data for selected programs from the Company’s diversified immuno-oncology pipeline at the American Society of Clinical Oncology (&...

2024-05-20 17:17:41 ET Summary Moderna's individualized neoantigen therapy, mRNA-4157, is a cancer vaccine with potential in multiple cancer types. mRNA-4157 has produced compelling results in stage III/IV melanoma patients, where a combination with pembrolizumab reduced the risk ...